The Increasing Amount of Research in the Field of Cell Therapy has Been Propelling the Market Growth

Cell therapy relies on the replacement of diseased or dysfunctional cells with healthy functional cells through injection, transplantation or implantation. Stem cells are mainly used for cell therapy. The stem cell therapy market includes a series of stem cell-based products that are used to treat various diseases such as cancer and tissue regeneration. With the growth of research, it is expected that the global cell therapy market will grow. The development of cell therapy, the adoption of regenerative medicine and the introduction of innovative technologies.

The report covers the driving factors, constraints and challenges in the field of cell therapy. In order to study the analysis in depth, the report is titled "Global Cell Therapy-Market and Technology Forecast to 2028", broken down by cell type, process and end user. The breakdown by end user is divided by North America, Europe, Asia Pacific, Middle East, and other parts of the world. Through the "cell processing", "cell preservation", "distribution and processing", "cell monitoring and quality control" and other processes, the "cell type" part is further divided into two parts. The subdivision process is classified according to the product: cell processing equipment, disposable equipment, systems and software, and others.

Increasing funds from government and private organizations to support clinical research in the field of cell therapy and the increasing popularity of regenerative drugs have promoted market growth in this field. Although, some strict government regulations may restrict the market. More and more scientific research in the field of stem cell therapy focuses on the therapeutic use of stem cells in the clinical treatment of diseases, and the introduction of stem cell lineage banks has helped drive the market. The development of induced pluripotent stem cell (iPSC) lines has also contributed to the growth of this market.
 

By 2028, the cell therapy market is expected to grow from USD 6 billion in 2020 to USD 9 billion. The market is expected to grow at a compound annual growth rate of 6%. The continuous growth of research in the field of cell therapy has promoted the growth of the market. The clinical application of cell therapy is expected to grow, and further promote the growth of the market. In addition, the demand for iPSC and hESC (human embryonic stem cells) is expected to surge.

Due to the existence of leading universities such as the Stem Cell Biology Institute of Stanford University and Yale University Stem Cell Center, NA is hereby leading the global cell therapy market. Moreover, the increase in financial assistance to the industry from countries such as the United States and Canada has further promoted the growth of the market. The Asia-Pacific region is the fastest and most profitable market for cell therapy. This is due to the continuous improvement of people's understanding of the process and the optimization of costs, which promote the development of this field.

Scope:
The report "Global Cell Therapy - Market and Technology Forecast to 2028" is segmented based on component, system type, and region. The study period is 2018- 2028 and the forecast period is 2020-2028.

Reasons to Buy: